ELEVATUM Study:Roche’ Vabysmo Enhances Vision In Underrepresented Diabetic Macular Edema Populations

(RTTNews) – Roche (RHHBY) announced positive topline one-year results from the open-label, single-arm phase IV ELEVATUM study evaluating Vabysmo (faricimab) for the treatment of diabetic macular edema (DME) in people from racial and ethnic groups that are often underrepresented i

admin